{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T20:01:18Z","timestamp":1771358478558,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41433-025-04139-9","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T05:37:32Z","timestamp":1765258652000},"page":"153-156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The ophthalmologist\u2019s guide to clinical practice guidelines: the GRADE evidence-to-decision frameworks and GRADE-Adolopment"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5486-7211","authenticated-orcid":false,"given":"Jo\u00e3o Pedro","family":"Lima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dena","family":"Zeraatkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessyca","family":"Matos Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Briana","family":"Carciumaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8734-3089","authenticated-orcid":false,"given":"David H.","family":"Steel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8448-1264","authenticated-orcid":false,"given":"Tien Yin","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlie C.","family":"Wykoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9988-4146","authenticated-orcid":false,"given":"Varun","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"On behalf of the Retina Evidence and Trials INternational Alliance (R.E.T.I.N.A.) Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohit","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles C.","family":"Wykoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sobha","family":"Sivaprasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Sarraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie J.","family":"Bakri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunir J.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishi P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank G.","family":"Holz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tien Y.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn H.","family":"Guymer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Steel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SriniVas R.","family":"Sadda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"4139_CR1","unstructured":"World Health Organization. Handbook for guideline development. 2nd ed. (WHO, 2014)."},{"key":"4139_CR2","doi-asserted-by":"publisher","first-page":"E839","DOI":"10.1503\/cmaj.090449","volume":"182","author":"MC Brouwers","year":"2010","unstructured":"Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182:E839\u2013E42.","journal-title":"CMAJ"},{"key":"4139_CR3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.7326\/M18-2950","volume":"170","author":"JJ Jue","year":"2019","unstructured":"Jue JJ, Cunningham S, Lohr K, Shekelle P, Shiffman R, Robbins C, et al. Developing and testing the agency for healthcare research and quality\u2019s national guideline clearinghouse extent of adherence to trustworthy standards (NEATS) instrument. Ann Intern Med. 2019;170:480\u20137.","journal-title":"Ann Intern Med"},{"key":"4139_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/gin2.70005","volume":"2","author":"Y Song","year":"2025","unstructured":"Song Y, Zhang Y, Amer Y, Darzi AJ, Akl EA, Alonso-Coello P, et al. The development of the GIN-McMaster checklist extension for guideline adaptation protocol. Clin Public Health Guidel. 2025;2:e70005.","journal-title":"Clin Public Health Guidel"},{"key":"4139_CR5","unstructured":"Institute of Medicine Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. In: Graham R, Mancher M, Miller Wolman D, Greenfield S, Steinberg E, editors. Clinical practice guidelines we can trust. National Academies Press (US) Copyright 2011 by the National Academy of Sciences, Washington (DC); 2011."},{"key":"4139_CR6","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924\u20136.","journal-title":"BMJ"},{"key":"4139_CR7","doi-asserted-by":"publisher","first-page":"e081903","DOI":"10.1136\/bmj-2024-081903","volume":"389","author":"G Guyatt","year":"2025","unstructured":"Guyatt G, Agoritsas T, Brignardello-Petersen R, Mustafa RA, Rylance J, Foroutan F, et al. Core GRADE 1: overview of the Core GRADE approach. BMJ. 2025;389:e081903.","journal-title":"BMJ"},{"key":"4139_CR8","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1038\/s41433-024-02937-1","volume":"38","author":"D Zeraatkar","year":"2024","unstructured":"Zeraatkar D, Pitre T, Phillips M, Steel DH, Wykoff CC, Wong TY, et al. The ophthalmologist\u2019s guide to evaluating the certainty of evidence using the GRADE approach. Eye. 2024;38:1601\u20134.","journal-title":"Eye"},{"key":"4139_CR9","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/s41433-021-01898-z","volume":"36","author":"AJ Darzi","year":"2022","unstructured":"Darzi AJ, Busse JW, Phillips MR, Singh RP, Holz FG, Thabane L, et al. Guidelines for patient management: considerations before adoption into practice. Eye. 2022;36:1135\u20137.","journal-title":"Eye"},{"key":"4139_CR10","doi-asserted-by":"publisher","first-page":"i2016","DOI":"10.1136\/bmj.i2016","volume":"353","author":"P Alonso-Coello","year":"2016","unstructured":"Alonso-Coello P, Sch\u00fcnemann HJ, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, et al. GRADE evidence to decision (EtD) frameworks: a systematic and transparent approach to making well-informed healthcare choices. 1: Introduction. BMJ. 2016;353:i2016.","journal-title":"BMJ"},{"key":"4139_CR11","first-page":"Cd001211","volume":"3","author":"YY Chen","year":"2023","unstructured":"Chen YY, Liu SH, Nurmatov U, van Schayck OC, Kuo IC. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev. 2023;3:Cd001211.","journal-title":"Cochrane Database Syst Rev"},{"key":"4139_CR12","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","volume":"66","author":"J Andrews","year":"2013","unstructured":"Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck-Ytter Y, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol. 2013;66:719\u201325.","journal-title":"J Clin Epidemiol"},{"key":"4139_CR13","doi-asserted-by":"publisher","first-page":"e083867","DOI":"10.1136\/bmj-2024-083867","volume":"389","author":"G Guyatt","year":"2025","unstructured":"Guyatt G, Vandvik PO, Iorio A, Agarwal A, Yao L, Eachempati P, et al. Core GRADE 7: principles for moving from evidence to recommendations and decisions. BMJ. 2025;389:e083867.","journal-title":"BMJ"},{"key":"4139_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s44158-023-00094-7","volume":"3","author":"JP Lima","year":"2023","unstructured":"Lima JP, Mirza RD, Guyatt GH. How to recognize a trustworthy clinical practice guideline. J Anesth Analg Crit Care. 2023;3:9.","journal-title":"J Anesth Analg Crit Care"},{"key":"4139_CR15","first-page":"e20230167","volume":"49","author":"JP Lima","year":"2023","unstructured":"Lima JP, Chu X, Guyatt GH, Tangamornsuksan W. Certainty of evidence, why? J Bras Pneumol. 2023;49:e20230167.","journal-title":"J Bras Pneumol"},{"key":"4139_CR16","unstructured":"The Royal College of Ophthalmologists. Idiopathic full thickness macular holes: clinical guideline. 2024. Accessed August 11, 2025. https:\/\/www.rcophth.ac.uk\/wp-content\/uploads\/2024\/10\/DRAFT-clinical-guideline-on-idiopathic-full-thickness-macular-holes.pdf."},{"key":"4139_CR17","doi-asserted-by":"crossref","unstructured":"Vemulakonda GA, Bailey ST, Kim SJ, Kovach JL, Lim JI, Ying GS, et al. American Academy of Ophthalmology Preferred Practice Pattern Retina\/Vitreous Committee. Age-related macular degeneration preferred practice pattern\u00ae. Ophthalmology. 2025;132:P1\u201374.","DOI":"10.1016\/j.ophtha.2024.12.018"},{"key":"4139_CR18","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1001\/jama.2021.15319","volume":"326","author":"R Brignardello-Petersen","year":"2021","unstructured":"Brignardello-Petersen R, Carrasco-Labra A, Guyatt GH. How to interpret and use a clinical practice guideline or recommendation: users\u2019 guides to the medical literature. JAMA. 2021;326:1516\u201323.","journal-title":"JAMA"},{"key":"4139_CR19","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/acr.23871","volume":"71","author":"ST Angeles-Han","year":"2019","unstructured":"Angeles-Han ST, Ringold S, Beukelman T, Lovell D, Cuello CA, Becker ML, et al. 2019 American College of Rheumatology\/Arthritis Foundation Guideline for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis. Arthritis Care Res. 2019;71:703\u201316.","journal-title":"Arthritis Care Res"},{"key":"4139_CR20","unstructured":"Department of Health, Republic of South Africa. South African National Essential Medicine List\u2013Primary Healthcare\/Adult Hospital Level of Care Medication Review Process\u2013Component: Eye conditions 2023."},{"key":"4139_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2024.111494","volume":"174","author":"M Klugar","year":"2024","unstructured":"Klugar M, Lotfi T, Darzi AJ, Reinap M, Klugarov\u00e1 J, Kantorov\u00e1 L, et al. GRADE guidance 39: using GRADE-Adolopment to adopt, adapt or create contextualized recommendations from source guidelines and evidence syntheses. J Clin Epidemiol. 2024;174:111494.","journal-title":"J Clin Epidemiol"},{"key":"4139_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jclinepi.2016.09.009","volume":"81","author":"HJ Sch\u00fcnemann","year":"2017","unstructured":"Sch\u00fcnemann HJ, Wiercioch W, Brozek J, Etxeandia-Ikobaltzeta I, Mustafa RA, Manja V, et al. GRADE evidence to decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-Adolopment. J Clin Epidemiol. 2017;81:101\u201310.","journal-title":"J Clin Epidemiol"},{"key":"4139_CR23","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.cmi.2024.02.003","volume":"30","author":"L Moja","year":"2024","unstructured":"Moja L, Zanichelli V, Mertz D, Gandra S, Cappello B, Cooke GS, et al. WHO\u2019s essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections. Clin Microbiol Infect. 2024;30:S1\u2013s51.","journal-title":"Clin Microbiol Infect"},{"key":"4139_CR24","first-page":"390","volume":"50","author":"R Berard","year":"2023","unstructured":"Berard R, Ng HY, Human A, Piskin D, Dhalla M, Gottlieb C, et al. Canadian rheumatology association recommendations for the screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis. J Rheumatol. 2023;50:390\u20139.","journal-title":"J Rheumatol"}],"updated-by":[{"DOI":"10.1038\/s41433-026-04252-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000}}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04139-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04139-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04139-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T19:02:59Z","timestamp":1771354979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-04139-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4139"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-04139-9","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Since online publication of this article, it has been noted that Varun Chaudhary was omitted from the list of Retina Evidence and Trials INternational Alliance (R.E.T.I.N.A.) Study Group members.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41433-026-04252-3","URL":"https:\/\/doi.org\/10.1038\/s41433-026-04252-3","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JPL: None. DZ: None. JMS: None. BC: None. DHS: Consultant for Alcon, BVI, DORC, Roche, Alimera, Eyepoint, Complement Therapeutics, Sitala, AviadoBio; Research funding: Alcon, Bayer, DORC, BVI, Boehringer-Ingelheim. TYW: TYW is a consultant for Astellas, Bayer, Boehringer-Ingelheim, Genentech, Iveric Bio, Novartis, Oxurion, Plano, Roche, Sanofi, and Shanghai Henlius. He is an inventor, holds patents and is a co-founder of start-up companies EyRiS and Visre, which have interests in and develop digital solutions for eye diseases. CCW: CCW reports consulting for 4DMT, AbbVie, Adverum, Alcon, Alimera, Alkeus, Annexon, Apellis, Aviceda, Bayer, Biocryst, Boehringer Ingelheim, Clearside, EyeBiotech, EyePoint, Genentech, InGel, Janssen, Kiora, KodiakMerck, Neurotech, Novartis, Ocuphire, ONL, Opthea, Osanni, Panther, Perceive Bio, Ray, Regeneron, RegenXBio, Sanofi, Santen, Stealth, Valo, Zeiss. VC: VC reports acting as an advisory board member, grants and other from Novartis; acting as an advisory board member, grants and other from Bayer; grants from Allergan; acting as an advisory board member and grants from Roche; acting as an advisory board member for Janssen; acting as an advisory board member for Apellis; acting as an advisory board member for Boehringer Ingelheim, and acting as an advisory board member for EyePoint outside the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}